The juridical process between Brighter and its former development partner
HotSwap (now renamed to Amundsen Management and Amundsen Engineering) is now
concluded. The arbitrator determined, in accordance with Brighter’s claims
against the company, that HotSwap has been careless in their efforts.
– We wouldn’t have carried out this process if we were not confident of our
case, but it feels very good that the matter now also is finalized from a legal
perspective. Now we can put this behind us and fully focus on the future and the
upcoming launch of Actiste, says Truls Sjöstedt, Brighter’s CEO and founder.
In accordance with the ruling Brighter will receive a compensation of SEK 500
000 from HotSwap. Further information regarding this subject can be found in
Brighter’s press release (http://news.cision.com/se/brighter-ab--publ
-/r/brighter-har-inlett-juridisk-process-om-ersattning-fran-hotswap,c9819982)
issued August 26, 2015 (Swedish only).
Simultaneously, Brighter pursued additional legal actions against HotSwap
regarding a patent dispute. In June 2016 Brighter announced that the company
secured all rights in the patent dispute and that Hotswap waives all claims to
ownership.
For further information, please contact:
Henrik Norström, COO
Phone: 46 733 40 30 45
henrik.norstrom@brighter.se
Truls Sjöstedt, CEO
Phone: 46 709 73 46 00
truls.sjostedt@brighter.se
About Actiste
Brighter’s subscription service solution Actiste® simplifies insulin-treated
diabetes by gathering all the most important functions in a connected device
with which the diabetic can measure blood sugar levels, set dosage and inject
insulin, as well as automatically log and share information.
About Brighter AB (publ)
Brighter develops solutions for data-driven and mobile health services. Through
its intellectual property and innovative tools, jDome® and Actiste®, the company
creates a more efficient care chain with focus on the individual. The goal is to
simplify, streamline and enhance the information flow of relevant and reliable
data between the patient and health care professionals. Brighter is initially
focused on diabetes care and care for the elderly, but there are opportunities
in the future to operate on a broader level, spanning more diseases and
treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud
-based service that continuously collects, analyzes and shares data on the
user's terms.
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s
Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 – 454
32 50, CorporateFinance@remium.com, www.remium.com.
This information is information that Brighter AB is obliged to make public
pursuant to the EU Market Abuse Regulation. The information was submitted for
publication, through the agency of the contact persons set out above, at 08:30
CET on October 12 2016.
